Vice President, Head Clinical Pharmacology, Bioanalytical & Pharmacometrics
Gilead Sciences
Foster City , California
As the Head of Clinical Pharmacology at Gilead Sciences, Dr. Girish provides strategic and scientific leadership for clinical pharmacology, pharmacometrics and bioanalytical strategies for NMEs spanning both early and late stages of development. Her department is actively involved in a variety of pediatric and adult R&D programs across virology, oncology, and inflammation and is responsible for integrated clinical pharmacology, and M&S strategies, including applying MIDD approaches where appropriate. Sandhya is passionate about combining insights from clinical trials with data from virtual clinical trials, RWD, AI/ML, genomics to accelerate drug development.
Dr. Girish has over two decades of experience in the development of multiple modalities at start-up (Genesoft), CRO (SRI International) and big pharma companies (Novartis and Roche/Genentech). In addition, she served as an IQ Board Member and was the Chair of the Clinical Pharmacology Leadership Group (CPLG) of the IQ Consortium (2017-2020). Sandhya was the recipient of a Rising Star Award in 2020 from the Healthcare Businesswomen’s Association.
Dr. Girish has numerous poster presentations, invited talks, publications and has received several awards for her contributions. Dr. Girish obtained her M.S. and Ph.D. degrees from Northeastern University, Boston and Bachelors in Pharmacy from India.
Disclosure information not submitted.
Monday, October 17, 2022
8:30 AM – 9:00 AM ET
Monday, October 17, 2022
9:00 AM – 10:30 AM ET